Trials / Completed
CompletedNCT07022730
Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension
The Novel Use of Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension in Patients With Surgical Sepsis, a Double Blind Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
researchers aim to evaluate the influence of prophylactic noradrenaline infusion on post-induction hypotension
Detailed description
If post-induction hypotension is not addressed promptly, it can lead to severe complications such as reduced blood flow, acute kidney damage, and myocardial ischemia. As a result, early detection and proactive intervention are crucial. Researchers of the current study decided to investigate impact of noradrenaline administered as a prophylaxis on post induction hypotension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Noradrenaline 0.2 mcg/kg/min at 5 minutes before induction | noradrenaline will be given at a rate of 0.2 mcg/kg/min that will start 5 minutes before induction |
Timeline
- Start date
- 2025-06-22
- Primary completion
- 2025-09-17
- Completion
- 2025-09-17
- First posted
- 2025-06-15
- Last updated
- 2025-09-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07022730. Inclusion in this directory is not an endorsement.